Status:
RECRUITING
Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI
Lead Sponsor:
Shenyang Northern Hospital
Conditions:
STEMI - ST Elevation Myocardial Infarction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of the study is to elucidate whether guiding by a novel artificial intelligence assisted mobile application can improve the clinical outcomes of patients in whom "guide wire passing through th...
Eligibility Criteria
Inclusion
- (the following inclusion conditions shall be met at the same time):
- age: ≥ 18 years and ≤ 80 years;
- Chest pain lasted for more than 30 min, and the onset time of chest pain was ≤ 12 hours;
- ECG: ST segment elevation after J-point in 2 or more adjacent leads: limb leads ≥ 0.1 mv or chest leads ≥ 0.2 mv;
- it is expected that "guide wire passing through the lesion" could not be achieved within 120 min after the diagnosis of STEMI;
- Signed informed consent .
Exclusion
- (1) Cardiac rupture; (2) Complete left bundle branch block (LBBB) or ventricular pacing; (3) There are contraindications to thrombolysis; (4) Have serious comorbidities; (5) Have complex heart disease; (6) There are situations that are not suitable for clinical trials.
Key Trial Info
Start Date :
September 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2029
Estimated Enrollment :
3356 Patients enrolled
Trial Details
Trial ID
NCT07160491
Start Date
September 8 2025
End Date
July 31 2029
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
No. 83, Wenhua Road, Shenhe District, Shenyang City
Shenyang, Liaoning, China